Atea Pharmaceuticals
AVIR
AVIR
141 hedge funds and large institutions have $1.99B invested in Atea Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 42 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+39
Holders Change %
+38.24%
% of All Funds
2.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
57
Increased
42
Reduced
30
Closed
17
Calls
$13M
Puts
$11.8M
Net Calls
+$1.23M
Net Calls Change
+$2.25M
Top Buyers
1 |
Viking Global Investors
Stamford,
Connecticut
|
$58M |
2 |
BlackRock
New York
|
$145M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$182M |
4 |
Geode Capital Management
Boston,
Massachusetts
|
$36.2M |
5 |
Goldman Sachs
New York
|
$25M |